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Introduction {#sec1-1}
============

Glomus tumors, which account for less than 2% of all soft tissue tumors, are benign neoplasms originating from glomus cells surrounding an arteriovenous anastomosis.^[@ref1]^ These tumors typically occur in the skin corium, and are extremely uncommon in the thorax where glomus bodies are thought to be absent. To date, fewer than 40 tracheal glomus tumors have been reported. In this report we describe the staged endobronchoscopic and surgical management of 51-yearold female who presented with dysphagia, hemoptysis and dyspnea as a result of mass effect from a glomus tumor of the distal trachea.

Case Report {#sec1-2}
===========

A 51-year-old female was admitted after several weeks of dysphagia, hemoptysis and increasing dyspnea. On admission, she was hemodynamically stable with normal oxygenation saturation on room air. Her laboratory values were unremarkable. A CT-angiogram of the chest revealed a nearly occlusive 2.6×2.3×1.7 cm intraluminal tracheal mass, just proximal to the carina ([Figure 1a](#fig001){ref-type="fig"}). ^18^FDG-PET visualized a hypermetabolic 2.6 cm retrotracheal lesion ([Figure 1b](#fig001){ref-type="fig"}). There was no evidence of FDG-avid distant metastasis of lymphadenopathy. Pharyngoesophagram revealed a smooth-surfaced extrinsic mass effect on the right lateral wall of the proximal thoracic esophagus with an associated esophageal diameter of 1.1 cm ([Figure 1c](#fig001){ref-type="fig"}).

The patient underwent bronchoscopy with endoscopic ultrasound. The distal trachea was 80% obstructed by extrinsic compression from the posterior membrane ([Figure 2a-c](#fig002){ref-type="fig"}). The right and left bronchial tree appeared to be normal. Complete endobronchial ultrasound (EBUS) scanning of mediastinum localized the posterior tracheal mass ([Figure 2d](#fig002){ref-type="fig"}). Transbronchial needle aspiration (TBNA) of the mass, Level 7 and Level 11 lymph node stations were obtained. For symptomatic relief, a silastic Y-stent was placed ([Figure 2e-g](#fig002){ref-type="fig"}).

Cytologic evaluation of TBNA samples revealed polygonal and round cells closely packed, with round nuclei, dispersed chromatin, and moderate amount of clear and eosinophilic cytoplasm, supported by delicate stroma with dilated blood vessels. Immunohistochemical (IHC) analysis demonstrated neoplastic cells which were vimentin and SMA positive, suggestive of a glomus tumor. Level 7 and Level 11L lymph node aspirates were negative for neoplastic cells.

The patient was referred to Thoracic Surgery, and resection was recommended. At the time of right thoracotomy, the tumor was discovered to be located deep to the azygous vein, embedded between the esophagus and trachea ([Figure 3](#fig003){ref-type="fig"}). After further dissection it was noted that the tumor was adherent to the posterior membranous wall of the trachea. Therefore, the posterior tracheal wall was resected en bloc with the tumor. The posterior wall of the trachea was reconstructed with bovine pericardium ([Figure 4](#fig004){ref-type="fig"}) and reinforced with an intercostal muscle flap.

Gross pathologic evaluation of the tumor revealed a 1.9×1.9×1.5 cm nodule. Histologic analysis revealed neoplastic cells with appreciable mitotic activity, but lacking nuclear pleomorphism ([Figure 5a](#fig005){ref-type="fig"}). The specimen was diffusely immunoreactive for smooth muscle actin, consistent with a glomus tumor ([Figure 5b](#fig005){ref-type="fig"}).

Postoperatively the patient recovered uneventfully and was discharged on postoperative day 5. The patient is now 17 months out from her resection, and surveillance bronchoscopy at 6 months and 12 months have demonstrated an intact repair with no evidence of recurrent disease.

Discussion {#sec1-3}
==========

Glomus tumors are exceedingly rare mesenchymal neoplasms which originate from perivascular smooth muscles cells responsible for thermoregulation. These tumors may arise in any part of the body, with the most common location being the subungueal area. In our report, we describe a patient presenting with a glomus tumor originating from the posterior tracheal wall. In addition to the trachea, extracutaneous glomus tumors have been identified within intrathoracic locations including the esophagus and lung.^[@ref2]^ As seen in the presented patient, glomus tumors are histologically marked by a characteristic pattern of nests of clear epithelioid cells intimately associated with branching vascular channels, all within a connective tissue stroma with variable hyaline and myxoid changes. Each cell is surrounded by a sharply-defined basal lamina. Glomus tumors are positive for vimentin and smooth muscle actin, show variable expression of desmin, caldesmon, calponin and CD34 and are negative for keratins, neuroendocrine markers, CD31, S100 and CKIT.

Only 40 glomus tumors of the trachea have been documented since being first described by Hussarek and Reider in 1950.^[@ref5]^ In all reported cases, tumors arise from the membranous wall of the trachea where there is an increased density of mucous glands and vessels.^[@ref6]^ As seen in [Table 1](#table001){ref-type="table"}, the mean age at presentation is 51 (range 10-83), with males more likely to be affected in comparison to females (60% *versus* 40%). The most common location is the distal trachea (54%), followed by the proximal trachea (24%), then the middle trachea (22%). The mean tumor size was found to be 2.0 cm (range 1.2-3.0 cm).

Of the 40 reported tracheal glomus tumors, most are benign with only 2 (5.0%) displaying malignant histology.^[@ref1],[@ref4]^ Given the potential for occult malignancy and the commonly symptomatic nature of the glomus tumor, resection is the standard of care. Most reports (67.5%) describe open resection; however, endoscopic resection has been reported ([Tables 1](#table001){ref-type="table"} and [2](#table002){ref-type="table"}).^[@ref5],[@ref7]^ The utilization of endoscopic resection has become more common with endoscopic resections accounting for 12.5% of resections prior to 2005 *versus* 42.8% after 2005; P=0.04. In the proper patient in which malignancy has been ruled out, an endoscopic approach appears to be reasonable as survivals are similar between the two approaches (median survival of 18.0 months in open resection group vs. 18.5 months in the endoscopic groups; P=0.94). Despite similarities in survival, definitive conclusion based on published retrospective reports is impossible given the lack of long-term follow-up data reported. With regard to the patient we report, an open resection was ultimately recommended based on the location, which would have resulted in a challenging resection via endoscopic approaches.

Conclusions {#sec1-4}
===========

In summary, glomus tumors of the trachea are rare neoplasms, with 40 reported cases to date. In this report, we describe our management of a stereotypical patient presenting with a symptomatic glomus tumor of the distal trachea. We further summarize descriptive and survival data obtained from all documented reports. From these data we conclude that most patients present with symptomatic lesions, and thus require resection. There is an increasing trend to resect these lesions endoscopically with similar long-term results as compared to open resection. Despite this data, when considering endoscopic versus open resection, we urge careful consideration for tumor location and an estimated 5% risk of malignancy.
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![a) Computed tomography angiogram of the chest demonstrating a 2.6×2.3×1 cm intraluminal tracheal mass arising from the posterior wall of the trachea just above the carina. Significant narrowing of the tracheal lumen was noted. b) ^18^FDG-Positron Emission Tomography revealing a solitary hypermetabolic, 2.2×1.8 cm mass arising from the posterior wall of the trachea and just above the level of the azygous vein. No lesions suspicious metastases were noted. c) Pharyngoesophagram demonstrating smooth extrinsic compression on the right lateral aspect of the proximal thoracic esophagus suggestive of a mediastinal mass.](rt-2017-1-6848-g001){#fig001}

![Bronchoscopy revealing clinically significant narrowing of the trachea with views from the (a) proximal trachea, (b) distal trachea and (c) carina. d) Endoscopic ultrasound revealing a 2.3 cm retrotracheal mass. Silastic Y-stent was placed covering the lesion with (e) overlap in the proximal trachea, (f) overlap in left mainstem bronchus and (g) fenestration to the right mainstem bronchus.](rt-2017-1-6848-g002){#fig002}

![Via right thoracotomy, the pleura overlying the tumor was excised. The glomus (Gl) tumor was firmly adherent to the trachea (Tr) and vagus (V), and it was displacing the esophagus (Eso) by mass effect. The right main bronchus (RMB) was distal and uninvolved.](rt-2017-1-6848-g003){#fig003}

![Following resection, the patch repair (PR) of the trachea (TR) could be visualized. The vagus (V) nerve was displaced anteriorly, and the esophagus (Eso) was located posteriorly. The right main bronchus (RMB) was located distally and could easily be visualized because the azygous vein was divided during the course of the operation.](rt-2017-1-6848-g004){#fig004}

![a) Hematoxylin and eosin staining of mediastinal mass revealing nests of clear epithelioid cells intimately associated with branching vascular channels. The neoplastic cells lack nuclear pleomorphism and appreciable mitotic activity. No necrosis, vascular, lymphatic or perineural invasion was identified. b) Immunohistochemical staining demonstrating diffuse immunoreactivity for smooth muscle actin.](rt-2017-1-6848-g005){#fig005}

###### 

Characteristics of all reported patients presenting with tracheal glomus tumor.

  Characteristic                                                    Value
  ----------------------------------------------------------------- ---------------
  Age in years, mean (range)                                        51 (10-83)
  Gender, n (%)                                                     
      Male                                                          24(60)
      Female                                                        16(40)
  Tumor size in cm, mean (range)[\*](#t1fn1){ref-type="table-fn"}   2.0 (1.2-3.0)
  Tumor location, n (%)                                             
      Proximal                                                      10(24)
      Middle                                                        9(22)
      Distal                                                        22(54)
  Type of resection, n (%)[\*\*](#t1fn2){ref-type="table-fn"}       
      Open                                                          27 (67.5)
      Endoscopic                                                    10(25)
      Other                                                         1 (2.5)

\*Tumor size describes lesion's greatest diameter

\*\*Resections described in [Table 2](#table002){ref-type="table"}.

###### 

Reported cases of tracheal glomus tumor.

  Authors                           Year   Age, sex   Presenting symptoms                   Tracheal location   Size, cm      Treatment                            Follow-up
  --------------------------------- ------ ---------- ------------------------------------- ------------------- ------------- ------------------------------------ --------------
  Hussarek & Reider^[@ref5]^        1950   43, F      Dyspnea                               Proximal trachea    Bean-sized    Trach. Res.                          N/D
  Fabich & Hafez^[@ref7]^           1980   63, M      Dyspnea                               Distal trachea      2.5×2.0×1.0   Trach. Res                           Sepsis-death
  Heard *et al*.^[@ref8]^           1982   50, M      Asthma-like                           Distal trachea      2.5×1.5×1.0   Trach. Res                           24 mth-NR
  Ito *et al*.^[@ref9]^             1988   51, M      Hemopytsis                            Proximal trachea    1.5×1.2×1.0   Trach. Res                           N/D
  Kim *et al*.^[@ref10]^            1989   54, F      Asthma-like                           Mid-trachea         1.5×1.2       Trach. Res                           13 month-NR
  Shin *et al.^[@ref11]^*           1990   47, F      Hemopytsis                            Distal trachea      1.5×1.0×1.0   Trach. Res                           N/D
  Gracia-Prats *et* al.^[@ref12]^   1991   58, M      Cough, dyspnea                        Mid-trachea         2.5×1.8       Trach. Res                           8 mth-NR
  Haraguchi *et al*.^[@ref13]^      1991   61, M      Asymptomatic                          Mid-trachea         1.2           Trach. Res                           N/D
  Arapantoni *et* al.^[@ref14]^     1998   65, M      Hemopytsis, dyspnea                   Distal trachea      Fragments     End. Res., Nd-YAG                    12 mth-NR
  Watanabe *et* al.^[@ref15]^       1995   65, M      Hoarseness                            Distal trachea      2.0×1.6×1.4   Trach. Res                           20 mth-NR
  Koskinen *et* al.^[@ref16]^       1998   66, M      Asymptomatic                          Distal trachea      N/D           Nd-YAG; external radiation therapy   N/D
  Menaissy *et al*.^[@ref17]^       1999   34, M      Hemopytsis                            Mid-trachea         2.4×2.1×1.6   Trach. Res                           4 mth-NR
  Gowan *et* al.^[@ref18]^          2000   73, M      Dyspnea, hemopytsis                   Mid-trachea         1.6×1.3×0.6   Trach. Res                           72 mth-NR
  Chien *et* al.^[@ref19]^          2002   50, F      Dyspnea, hemopytsis                   Distal trachea      2.5×2.5×2.0   Trach. Res                           12 mth-NR
  Nadrous *et al*.^[@ref20]^        2004   39, M      Hemopytsis                            Proximal trachea    2.0×1.5×1.5   Trach. Res                           N/D
  Ren *et al.^[@ref21]^*            2005   29, M      Cough                                 Distal trachea      2.0×1.7×1.7   Trach. Res                           N/D
  Altinok *et al*.^[@ref22]^        2006   83, F      Dyspnea, wheezing                     Proximal trachea    2.0×1.5×1.2   Trach. Res                           12 mth-NR
  Haver *et* al.^[@ref23]^          2008   10, F      Dyspnea                               Mid-trachea         1.8×1.3×1.3   Trach. Res                           24 mth-NR
  Colaut *et al.^[@ref24]^*         2008   70, M      Dyspnea, wheezing                     Mid-trachea         2.0×1.0×1.0   End. Res.; Nd-YAG                    24 mth-NR
  Parker *et al.^[@ref25]^*         2010   43, F      Dyspnea, wheezing                     Distal trachea      2.0×1.6×1.5   Trach. Res                           N/D
  Shang *et al.^[@ref26]^*          2010   59, M      Chest pain, dyspnea                   Distal trachea      2.0×1.0×0.5   End. Res.                            12 mth-NR
                                           22, F      Cough, dyspnea                        Distal trachea      2.0×1.0×1.0   End. Res.                            12 mth-NR
  Baek *et* al.^[@ref27]^           2011   54, M      Stridor                               Proximal trachea    3.0×2.3×1.3   Trach. Res                           24 mth-NR
  Mogi *et* al.^[@ref28]^           2011   56, F      Dyspnea                               Distal trachea      1.3×1.2×1.1   Trach. Res                           9 mth-NR
  Okereke *et* al.^[@ref29]^        2011   58, M      Stridor                               Mid-trachea         1.1           Trach. Res                           6 mth-NR
  Sakr *et* al.^[@ref30]^           2011   66, M      Dyspnea, stridor                      Proximal trachea    2.0×1.2×0.8   End. Res. and Trach. Res             21 mth-NR
  Cukurova *et* al.^[@ref31]^       2012   50, M      Cough, dyspnea, hemoptysis, stridor   Proximal trachea    N/D           Endosopic laser excision             36 mth-NR
  Norder *et al.^[@ref32]^*         2012   49, F      Cough, dyspnea                        Proximal trachea    1.2×1.1×1.1   End. Res.                            48 mth-NR
  Chang *et al.^[@ref33]^*          2013   76, M      Fever, dyspnea                        Mid-trachea         N/D           Patient refused further treatment    N/D
  Fan *et* al.^[@ref34]^            2013   15, M      Dyspnea, hemopytsis                   Distal trachea      2.3×2.0       Trach. Res                           N/D
  Ghigna *et al.^[@ref35]^*         2013   70, M      Hemopytsis                            Distal trachea      2.0           Trach. Res                           N/D
  Ghigna *et* al.^[@ref35]^         2013   \~40,M     Hemopytsis                            Distal trachea      1.0           Segmental Trach. Res                 N/D
  Aryan *et al.^[@ref36]^*          2014   50, F      Cough, dyspnea, hemopytsis            Distal trachea      N/D           End. Res.                            N/D
  Wu *et al.^[@ref37]^*             2014   58, F      Asymptomatic                          Distal trachea      2.2×2.2       Trach. Res                           24 mth-NR
  Huang *et al.^[@ref1]^*           2015   39, F      Dyspnea, stridor                      Proximal trachea    2.5×1.2       End. Res.                            1 month-NR
  Masoum *et al.*                   2015   21, M      Cough, hemopytsis                     Distal trachea      2.0           End. Res.                            1 month-NR
  Tan *et al.^[@ref6]^*             2015   44, M      Cough, dyspnea, hemopytsis            Distal trachea      3.0×2.5×1.0   Trach. Res                           20 mth-NR
  Wang *et* al.^[@ref38]^           2015   48, M      Hemopytsis                            Distal trachea      1.5×1.2×1.0   Endoscopic excision                  N/D
  Braham *et al.^[@ref39]^*         2016   74, M      Dyspnea                               Proximal trachea    2.9×2.3       Trach. Res                           30 mth-NR
  Present case                      2016   51, F      Dysphagia, hemoptysis, dyspnea        Distal trachea      2.6×2.3×1.7   Trach. Res                           12 mth-NR

F, Female; M, Male; N/D, not documented; mth, months; NR, no recurrence; Trach. Res., tracheal resection; End. Res., endoscopic resection; Nd-YAG, neodymium-yttrium-aluminum-garnet laser; Modified and updated from (17) and (6).
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